Previous 10 | Next 10 |
2023-11-02 09:00:00 ET Summary Pfizer's stock has dropped due to a decline in revenues post-COVID, presenting a value investment opportunity. The company still generates significant gross profit and has a strong revenue growth rate. Pfizer's low Price-to-Earnings ratio and imp...
2023-11-01 08:30:58 ET NetworkNewsWire Editorial Coverage New York, NY – November 1, 2023 – GLP-1 agonists have become incredibly popular obesity drugs, reshaping the standard of care as people increasingly turn to the new class of drugs in lieu of conventional...
Sanofi launches "The 1 Pledge" movement to drive early screening for type 1 diabetes in the U.S. PR Newswire Nationwide storytelling movement to showcase diverse voices of the type 1 diabetes community, including internationally recognized stars Usher, Robin Arzón, and ...
2023-10-31 15:25:10 ET Summary ImmunoGen, Inc.'s marketing authorization application for ELAHERE, a cancer therapy, has been accepted by the EMA. Rumors suggest that large European pharma companies, including GSK, Sanofi, or Merck, may be interested in ImmunoGen. ImmunoGen has...
2023-10-31 12:24:58 ET Summary Amicus Therapeutics, Inc. is a commercial-stage biotech company focused on developing therapies for rare diseases. The company recently received FDA approval for its combination therapy Pombiliti + Opfolda for Pompe disease. Amicus Therapeutics i...
2023-10-29 12:00:27 ET More on PBMs Cigna PBM unit Express Scripts sued for overcharging pharmacies FTC investigating purchasing organizations that work on behalf of PBMs Eli Lilly, Novo, Sanofi and leading PBMs accused in California over insulin prices CVS H...
2023-10-29 07:20:47 ET Summary Sanofi's Q3 2023 shows mixed results with net sales down 4.1% YoY, and operating income falling 11.2%. High-growth drugs Dupixent and Nexviazyme contrast starkly with declining assets like Lantus and Aubagio. Spin-off of Consumer Healthcare segme...
2023-10-27 14:26:06 ET Sanofi (SNY) Q3 2023 Earnings Conference Call October 27, 2023, 09:00 AM ET Company Participants Eva Schaefer-Jansen - Head of Investor Relations Paul Hudson - Chief Executive Officer Jean-Baptiste de Chatillon - Executive Vice President, C...
2023-10-27 12:55:24 ET More on Sanofi Sanofi Q3 2023 Earnings Preview: Expect Positive Results, But No Share Price Spike Sanofi: 3 Reasons For A Buy Sanofi: A 'Buy' Recommendation For Undervalued Growth Potential Sanofi stock dips on plans to spin off consume...
2023-10-27 10:02:45 ET More on Health Care Select Sector SPDR Health Care Select Sector Fund ETF: Riding The Healthcare Boom Stocks to watch in the Health Care sector as earnings close in BofA reports 10th consecutive week of equity inflows For further detail...
News, Short Squeeze, Breakout and More Instantly...
Sanofi ships U.S. influenza vaccines for the 2024/25 season PR Newswire Customers will start receiving shipments from July 10 with additional shipments through October to healthcare provider offices, pharmacies and other immunizers to support fall immunization campaigns. ...
2024-07-09 06:40:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...